These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 16599392)

  • 1. For the patient. Barriers and solutions to motivating men to undergo prostate cancer screening.
    Ethn Dis; 2006; 16(1):325. PubMed ID: 16599392
    [No Abstract]   [Full Text] [Related]  

  • 2. The needs of men with prostate cancer: results of a focus group study.
    Wallace M; Storms S
    Appl Nurs Res; 2007 Nov; 20(4):181-7. PubMed ID: 17996804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening practice and knowledge in Rhode Island.
    Glicksman AS; Meyer A; Cullinen K
    Med Health R I; 2009 Feb; 92(2):65-6. PubMed ID: 19288690
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
    Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
    Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.
    Shah M; Zhu K; Palmer RC; Wu H
    Prev Med; 2007 May; 44(5):459-64. PubMed ID: 17320159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer risk assessment program: a 10-year update of cancer detection.
    Giri VN; Beebe-Dimmer J; Buyyounouski M; Konski A; Feigenberg SJ; Uzzo RG; Hanks G; Godwin AK; Chen DY; Gordon R; Cescon T; Raysor S; Watkins-Bruner D
    J Urol; 2007 Nov; 178(5):1920-4; discussion 1924. PubMed ID: 17868726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC; Saigal CS
    Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between body mass index and prostate cancer screening in the United States.
    Scales CD; Curtis LH; Norris RD; Schulman KA; Dahm P; Moul JW
    J Urol; 2007 Feb; 177(2):493-8. PubMed ID: 17222617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus.
    Konety BR; Sharp VJ; Raut H; Williams RD
    Urology; 2008 Mar; 71(3):511-4. PubMed ID: 18342199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do women have a role in early detection of prostate cancer? - Lessons from a qualitative study.
    Madjar I; Denham J; Rashid P
    Aust Fam Physician; 2007 May; 36(5):375-7. PubMed ID: 17492077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center.
    Fitzgibbon ML; Ferreira MR; Dolan NC; Davis TC; Rademaker AW; Wolf MS; Liu D; Gorby N; Schmitt BP; Bennett CL
    Health Promot Pract; 2007 Jul; 8(3):273-81. PubMed ID: 17606952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation.
    Yasunaga H; Ide H; Imamura T; Ohe K
    Urology; 2006 Nov; 68(5):1046-50. PubMed ID: 17113896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information desired and acquired by men with prostate cancer: data from ethnic focus groups.
    Maliski SL; Connor S; Fink A; Litwin MS
    Health Educ Behav; 2006 Jun; 33(3):393-409. PubMed ID: 16699127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maori men's perceptions and experiences of health seeking for prostate health problems in New Zealand.
    Willams PN; Gray MA; Ka'ai TM; Moorfield JC; Mcpherson KM; Weinstein P; Nacey JN
    Pac Health Dialog; 2003 Sep; 10(2):71-8. PubMed ID: 18181419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.